Goldzieher J.W., Nezam M. Oral contraceptive side effects: where is the beef? Contraception.1995; 52: 327-5.
Barken M. B. Oral contraception and congenital malformation in offspring: a review and meta analysis of prospective studies. Obs Gyn. 1990; 76: 552-7.
Hormonal and non-hormonal agents at implantation as targets for contraception. Reprod Fertil Dev.1997; 9: 65-76.
Simon C., Pellicer A., Remohi J. Emerging concepts on human implantation. Hum Reprod. 1999; 14: (2).
Tabibzadeh S., Babaknia A. The signal and molecular pathways involved in implantation, a symbiotic interaction between blastocystis and endometrium involving adhesion and tissue invasion. Hum Reprod.1995; 10(6): 1579-602.
Psychoyos A. Hormonal control of uterine receptivity for nidation. J Reprod Fertil. 1976; 25: 17-28.
Nikas G. Pinopodes as marker of endometrial receptivity. Hum Rerod. 1999; 14 (12).
Senturk L.M., Arici A. Leukemia inhibitory factor in human reproduction. Am J Reprod Immunol. 1998; 39(2): 144-51.
Carson D.D., Tang Y., Gray S. Collagenase support. Embryo attachment and outgrowth in vitro. Dev Biol. 1988; 127:386.
Huang H. Y., Wen Y., Irwin J.C., et al. Cytocine mediated regulation of tissue inhibitors of metalloprotinase –1 (TIMP-1), TIMP-3 and 92 kDa type IV collagenase mRNA expression in.human endometrial stromal cells. J Clin Endocrinol Metab. 1988; 83: 1721-90.
Somon C., Valbuena D., Krussel J. Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium. Fertil Steril. 1998; 70: 896-906.
Reich R., Miskin R., Tsafrir A. Follicular plasminogen activator in ovulation. Endocrionl. 1985; 116:516-21.
Zhu C., Woessner J.F. Tissue inhibitor of metalloprotinase and alpha macroglobulins in the ovulating rat ovary: possible regulator of collagen matrix breakdown. Biol Repord. 1991; 45: 334-42.
Reich R. Tsafrir A., Mechanic G.L. The involvement of collagenas in ovulation in rat. Endocrinol. 1985; 116: 522-7.
Ward R.V., Atkinson S.J., Slocombe P.M., et al. The tissue inhibitor of metalloproteinases –2 inhibits the activation of 72Kda progelatinase by fibroblast membrane. Bioch et Biophy Acta. 1991; 1089:242-6.
Edward R.G. Review of implantation, interception and contraception. Hum Repord. 1994; 6:955-95.
Psychoyos A., Nikas G. Uterine pionpodes as marker of uterine receptivity. Assis Repord Rev. 1994; 4:23-6.
Hemmings R., Lachapelle M.H., Falcone T., et al. Effect of follicular fluid supplementation on the in vitro development of human pre-embryos. Fertil Steril. 1994; 62(5): 1018-21.
Chi H.J., Kim D.H., Koo J.J., et al. The suitability and efficiency of human follicular fluid as a protein supplement in human in vitro fertilization programs. Fertil Steril. 1998; 70(5): 871-7
Hung T.T., Millard. M.M. Inhibition of mouse embryo cleavage by factor present in the human preovulatory follicular fluid. J Clin Endocrinol Metab.1985; 61:899-904.
Rechtman M.P., Zhang J., Salamonsen L.A. Effect of inhibition of matrix metalloproteinases on endometrial decidualization and implantation in mated rats. J Repord Fertil. 1999; 117(1): 169-77.
Klentzeris L.D. The role of endometrium in implantation. Hum Repord. 1997; 2: 170-5.